Page last updated: 2024-10-27

flecainide and Double Outlet Right Ventricle

flecainide has been researched along with Double Outlet Right Ventricle in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Double Outlet Right Ventricle: Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murdoch, IA1
Priestley, KA1
Parsons, JM1

Other Studies

1 other study available for flecainide and Double Outlet Right Ventricle

ArticleYear
Dangerous recurrence of arrhythmia following withdrawal of flecainide.
    International journal of cardiology, 1990, Volume: 28, Issue:2

    Topics: Child, Preschool; Double Outlet Right Ventricle; Flecainide; Humans; Male; Substance Withdrawal Synd

1990